Publication
Co-treatment with pyrvinium pamoate and hispidulin potently reduces stemness and promotes mitochondrial apoptosis in prostate cancer cells.
Riza Serttas, Suat Erdogan
CytotechnologyOct 1, 2026PMID 42643730doi:10.1007/s10616-026-01056-x PMC13504029Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Pyrvinium pamoate, originally developed for protozoal infections, has emerged as a small-molecule inhibitor that interferes with Wnt/β-catenin signaling by suppressing β-catenin stability and downstream target gene activation. Wnt/β-catenin signaling pathway is a key intracellular regulatory…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.